ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Internal Medicine

Top Internal Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MOUNIR SHENOUDA MD

Internal Medicine

15,454

$1.29M

605
446 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $60

RIMMA POLOTSKAYA MD

Internal Medicine

17,710

$1.22M

330
301 are 65+

N/A

10%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $60

NADEEM ANSARI M.D.

Internal Medicine

13,538

$1M

410
368 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $60

JANUARIO ESTRADA M.D.

Internal Medicine

15,042

$999K

340
162 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $60

OLGA ZARKH MD

Internal Medicine

12,905

$879K

189
174 are 65+

N/A

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $60

PETER ROUMELIOTIS MD

Internal Medicine

14,238

$861K

439
396 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $60

BETTY GOLDSTEIN M.D.

Internal Medicine

9,966

$732K

423
377 are 65+

N/A

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$73
Average prescription price

Avg: $60

MARVIN PEIKEN MD

Internal Medicine

7,121

$707K

481
454 are 65+

N/A

6%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$99
Average prescription price

Avg: $60

ABDUL AZIZ MD

Internal Medicine

9,025

$704K

294
136 are 65+

N/A

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $60

ELEAZAR CALERO MD

Internal Medicine

8,279

$659K

361
319 are 65+

N/A

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $60

PATRICK TOWNE MD

Internal Medicine

9,535

$649K

521
478 are 65+

N/A

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $60

WILLIAM FRANKLIN M.D.

Internal Medicine

11,702

$636K

396
375 are 65+

N/A

12%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

SUSAN IGNATIUS MD

Internal Medicine

8,879

$599K

397
354 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $60

PRASANNA KUMAR M.D.

Internal Medicine

8,148

$591K

316
272 are 65+

N/A

18%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$73
Average prescription price

Avg: $60

ANDREY LEV-WEISSBERG MD

Internal Medicine

7,777

$563K

279
230 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $60

SCOTT KOLBABA MD

Internal Medicine

6,800

$562K

222
205 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $60

THOMAS GALLAGHER MD

Internal Medicine

7,722

$556K

536
498 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $60

GHANSHYAM SHAH M.D.

Internal Medicine

8,853

$556K

656
611 are 65+

N/A

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $60

JAIME SANZ MD

Internal Medicine

9,051

$554K

371
326 are 65+

N/A

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $60

MORRY ROTENBERG MD

Internal Medicine

7,155

$516K

447
431 are 65+

N/A

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $60

SANDRA GARRETSON MD

Internal Medicine

8,455

$509K

372
362 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $60

MANSOOR KHAN MD

Internal Medicine

7,955

$507K

353
311 are 65+

N/A

20%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $60

ARUN NARANG M.D.

Internal Medicine

7,726

$496K

254
210 are 65+

N/A

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $60

JONATHAN MAKS MD

Internal Medicine

7,410

$495K

318
305 are 65+

N/A

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $60

JAMES RICCI

Internal Medicine

9,333

$492K

489
441 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank